2016
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine
Nagarajah J, Le M, Knauf JA, Ferrandino G, Montero-Conde C, Pillarsetty N, Bolaender A, Irwin C, Krishnamoorthy GP, Saqcena M, Larson SM, Ho AL, Seshan V, Ishii N, Carrasco N, Rosen N, Weber WA, Fagin JA. Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine. Journal Of Clinical Investigation 2016, 126: 4119-4124. PMID: 27669459, PMCID: PMC5096947, DOI: 10.1172/jci89067.Peer-Reviewed Original ResearchConceptsThyroid cancerThyroid differentiation genesBRAF-mutant thyroid cancerIodide uptakeCancer cellsERK inhibitionERK signalingMEK inhibitor selumetinibThyroid cellsThyroid cancer cellsRAI therapyMaximal responseRadioiodide therapyCancerThyroid hormone biosynthesisOncogenic BRAFIodide accumulationPotent inhibitionDifferentiation genesTherapyMAPK signalingInhibitionIodide transportSignalingERK
2007
Amino Acid Residues in Transmembrane Segment IX of the Na+/I– Symporter Play a Role in Its Na+ Dependence and Are Critical for Transport Activity*
De la Vieja A, Reed MD, Ginter CS, Carrasco N. Amino Acid Residues in Transmembrane Segment IX of the Na+/I– Symporter Play a Role in Its Na+ Dependence and Are Critical for Transport Activity*. Journal Of Biological Chemistry 2007, 282: 25290-25298. PMID: 17606623, DOI: 10.1074/jbc.m700147200.Peer-Reviewed Original ResearchConceptsMembrane/cytosol interfaceActive I(-) transportAmino acid residuesPlasma membrane glycoproteinsBinding/translocationProtein familySegment IXNIS mutationPosition 354Asp-369NIS functionAcid residuesTransport activityMembrane glycoproteinsAmino acidsFunctional significanceResiduesSymporterI- transportKey roleSide chainsTranslocationTransportersThrHelix